NVCT
Nuvectis Pharma, Inc. · Healthcare
Chair, CEO and 10% owner Ron Bentsur bought $165K of Nuvectis Pharma, Inc.
Bought$165,220
$8.40Price
19,669Shares
+1%Stake
What NVCT did for a copier
- $1,000 copied at Tue, Aug 16 close, $9.17
- $795
- S&P 500, same days
- −13.4%
Measured over 30 trading days, to the Sep 28 close.
Ron Bentsur's record
11 other buys with 3 months of prices since 2022: on average +61.4% against the S&P 500, and 8 of 11 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Aug 11. Filed Tue, Aug 16, 12:05 PM ET, during the session. Returns use the Aug 16 close and the Sep 28 close. Not investment advice.